FDA Drug Application (090872) for SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number090872
Product Number001
FormTABLET; ORAL
Dosage85MG; 500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
Active IngredientSUMATRIPTAN SUCCINATE; NAPROXEN SODIUM



Back to FDA Applications sponsored by MYLAN PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.